Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga

Antiviral therapeutics with existing clinical safety profiles would be highly desirable in an outbreak situation, such as the 2013–2016 emergence of Ebola virus (EBOV) in West Africa. Although, the World Health Organization declared the end of the outbreak early 2016, sporadic cases of EBOV infectio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Chiramel, Abhilash I., Banadyga, Logan, Dougherty, Jonathan D., Falzarano, Darryl, Martellaro, Cynthia, Brees, Dominique, Taylor, R. Travis, Ebihara, Hideki, Best, Sonja M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Ebola Outbreak in West Africa
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5050471/
https://ncbi.nlm.nih.gov/pubmed/27511894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw241
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars